Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer

Kohei Jobu, Changhai Sun, Saburo Yoshioka, Junko Yokota, Masahide Onogawa, Chiaki Kawada, Keiji Inoue, Taro Shuin, Toshiaki Sendo, Mitsuhiko Miyamura

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

It has been reported that dogs are capable of identifying cancer in humans by detecting a specific odor: bladder cancer by detecting urine odor and other cancers by detecting exhaled breath odor. However, no odor recognized by dogs that indicates cancer has been identified. In this study, we examined whether bladder cancer could be detected by gas chromatography-mass spectrometry (GC-MS)-based metabolomics analysis of urine odor. Nine patients with bladder cancer and 7 healthy controls were recruited as participants. Patients collected urine 3 d before and for 3-7 d after surgery. The concentrated urine odor was analyzed by GC-MS and principal component analysis (PCA). Results indicated 12 metabolites of urine odor. Score plots of 7 of the preoperative bladder cancer patients were clearly different from those of controls on the PCA map. The distribution of controls was in the negative domain of principal component (PC) 1, whereas the distribution of preoperative patients was in the positive domain of PC1. Bladder cancer was diagnosed in 5 of the 9 patients on the basis of urinary cytology. The findings indicate the potential to screen bladder cancer by analyzing urine odor. Moreover, diagnosis of bladder cancer on the basis of urine odor might have higher sensitivity than screening by urinary cytology.

Original languageEnglish
Pages (from-to)639-642
Number of pages4
JournalBiological and Pharmaceutical Bulletin
Volume35
Issue number4
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Metabolomics
Urinary Bladder Neoplasms
Urine
Principal Component Analysis
Gas Chromatography-Mass Spectrometry
Cell Biology
Dogs
Odorants
Neoplasms

Keywords

  • Bladder cancer
  • GC-MS
  • Metabolomics
  • Urine odor

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer. / Jobu, Kohei; Sun, Changhai; Yoshioka, Saburo; Yokota, Junko; Onogawa, Masahide; Kawada, Chiaki; Inoue, Keiji; Shuin, Taro; Sendo, Toshiaki; Miyamura, Mitsuhiko.

In: Biological and Pharmaceutical Bulletin, Vol. 35, No. 4, 04.2012, p. 639-642.

Research output: Contribution to journalArticle

Jobu, K, Sun, C, Yoshioka, S, Yokota, J, Onogawa, M, Kawada, C, Inoue, K, Shuin, T, Sendo, T & Miyamura, M 2012, 'Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer', Biological and Pharmaceutical Bulletin, vol. 35, no. 4, pp. 639-642. https://doi.org/10.1248/bpb.35.639
Jobu, Kohei ; Sun, Changhai ; Yoshioka, Saburo ; Yokota, Junko ; Onogawa, Masahide ; Kawada, Chiaki ; Inoue, Keiji ; Shuin, Taro ; Sendo, Toshiaki ; Miyamura, Mitsuhiko. / Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer. In: Biological and Pharmaceutical Bulletin. 2012 ; Vol. 35, No. 4. pp. 639-642.
@article{b76781eab0a24a8f93648189e485bb0a,
title = "Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer",
abstract = "It has been reported that dogs are capable of identifying cancer in humans by detecting a specific odor: bladder cancer by detecting urine odor and other cancers by detecting exhaled breath odor. However, no odor recognized by dogs that indicates cancer has been identified. In this study, we examined whether bladder cancer could be detected by gas chromatography-mass spectrometry (GC-MS)-based metabolomics analysis of urine odor. Nine patients with bladder cancer and 7 healthy controls were recruited as participants. Patients collected urine 3 d before and for 3-7 d after surgery. The concentrated urine odor was analyzed by GC-MS and principal component analysis (PCA). Results indicated 12 metabolites of urine odor. Score plots of 7 of the preoperative bladder cancer patients were clearly different from those of controls on the PCA map. The distribution of controls was in the negative domain of principal component (PC) 1, whereas the distribution of preoperative patients was in the positive domain of PC1. Bladder cancer was diagnosed in 5 of the 9 patients on the basis of urinary cytology. The findings indicate the potential to screen bladder cancer by analyzing urine odor. Moreover, diagnosis of bladder cancer on the basis of urine odor might have higher sensitivity than screening by urinary cytology.",
keywords = "Bladder cancer, GC-MS, Metabolomics, Urine odor",
author = "Kohei Jobu and Changhai Sun and Saburo Yoshioka and Junko Yokota and Masahide Onogawa and Chiaki Kawada and Keiji Inoue and Taro Shuin and Toshiaki Sendo and Mitsuhiko Miyamura",
year = "2012",
month = "4",
doi = "10.1248/bpb.35.639",
language = "English",
volume = "35",
pages = "639--642",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer

AU - Jobu, Kohei

AU - Sun, Changhai

AU - Yoshioka, Saburo

AU - Yokota, Junko

AU - Onogawa, Masahide

AU - Kawada, Chiaki

AU - Inoue, Keiji

AU - Shuin, Taro

AU - Sendo, Toshiaki

AU - Miyamura, Mitsuhiko

PY - 2012/4

Y1 - 2012/4

N2 - It has been reported that dogs are capable of identifying cancer in humans by detecting a specific odor: bladder cancer by detecting urine odor and other cancers by detecting exhaled breath odor. However, no odor recognized by dogs that indicates cancer has been identified. In this study, we examined whether bladder cancer could be detected by gas chromatography-mass spectrometry (GC-MS)-based metabolomics analysis of urine odor. Nine patients with bladder cancer and 7 healthy controls were recruited as participants. Patients collected urine 3 d before and for 3-7 d after surgery. The concentrated urine odor was analyzed by GC-MS and principal component analysis (PCA). Results indicated 12 metabolites of urine odor. Score plots of 7 of the preoperative bladder cancer patients were clearly different from those of controls on the PCA map. The distribution of controls was in the negative domain of principal component (PC) 1, whereas the distribution of preoperative patients was in the positive domain of PC1. Bladder cancer was diagnosed in 5 of the 9 patients on the basis of urinary cytology. The findings indicate the potential to screen bladder cancer by analyzing urine odor. Moreover, diagnosis of bladder cancer on the basis of urine odor might have higher sensitivity than screening by urinary cytology.

AB - It has been reported that dogs are capable of identifying cancer in humans by detecting a specific odor: bladder cancer by detecting urine odor and other cancers by detecting exhaled breath odor. However, no odor recognized by dogs that indicates cancer has been identified. In this study, we examined whether bladder cancer could be detected by gas chromatography-mass spectrometry (GC-MS)-based metabolomics analysis of urine odor. Nine patients with bladder cancer and 7 healthy controls were recruited as participants. Patients collected urine 3 d before and for 3-7 d after surgery. The concentrated urine odor was analyzed by GC-MS and principal component analysis (PCA). Results indicated 12 metabolites of urine odor. Score plots of 7 of the preoperative bladder cancer patients were clearly different from those of controls on the PCA map. The distribution of controls was in the negative domain of principal component (PC) 1, whereas the distribution of preoperative patients was in the positive domain of PC1. Bladder cancer was diagnosed in 5 of the 9 patients on the basis of urinary cytology. The findings indicate the potential to screen bladder cancer by analyzing urine odor. Moreover, diagnosis of bladder cancer on the basis of urine odor might have higher sensitivity than screening by urinary cytology.

KW - Bladder cancer

KW - GC-MS

KW - Metabolomics

KW - Urine odor

UR - http://www.scopus.com/inward/record.url?scp=84859448583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859448583&partnerID=8YFLogxK

U2 - 10.1248/bpb.35.639

DO - 10.1248/bpb.35.639

M3 - Article

C2 - 22466574

AN - SCOPUS:84859448583

VL - 35

SP - 639

EP - 642

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 4

ER -